期刊文献+

紫杉醇联合榄香烯在晚期结肠癌患者中应用价值研究 被引量:2

Study on the value of paclitaxel combined with elemene in patients with advanced colon cancer
下载PDF
导出
摘要 目的:探讨紫杉醇联合榄香烯在晚期结肠癌患者中的应用价值。方法:收治晚期结肠癌患者60例,随机分为研究组与对照组各30例。对照组给予卡培他滨治疗,研究组给予紫杉醇联合榄香烯治疗。结果:研究组治疗总有效率、治疗满意度高于对照组(P<0.05)。结论:紫杉醇联合榄香烯在晚期结肠癌患者中应用价值极高,疗效佳,患者高度满意。 Objective:To investigate the clinical value of paclitaxel combined with elemene in patients with advanced coloncancer.Methods:60patients with advanced colon cancer were selected.They were randomly divided into the study group and thecontrol group with30cases in each group.The control group was treated with capecitabine,and the study group was treated withpaclitaxel combined with elemene.Results:The total effective rate and treatment satisfaction rate of the study group were higherthan those of the control group(P<0.05).Conclusion:Paclitaxel combined with elemene has high value in the treatment of patientswith advanced colon cancer,and has a satisfactory curative effect,and the patients are highly satisfied.
作者 董印权 卢国华 张英卫 董婷婷 Dong Yinquan;Lu Guohua;Zhang Yingwei;Dong Tingling(Department of Chinese and Western Medicine Oncology,the Ninth Hospital of Xingtai City,055250)
出处 《中国社区医师》 2017年第28期44-45,共2页 Chinese Community Doctors
关键词 晚期结肠癌 紫杉醇 榄香烯 Advanced colon cancer Paclitaxel Elemene
  • 相关文献

参考文献6

二级参考文献43

  • 1中国药典,一部[S].2010:263.
  • 2McKeown E,Nelson DW,Johnson EK,et al.Current approaches and challenges for monitoring treatment response in colon and rectal cancer[J].J Cancer,2014,5(1):31-43.
  • 3Tsujii M.Search for novel target molecules for the effective treatment or prevention of colorectal cancer[J].Digestion,2012,85(2):99-102.
  • 4Ojima E,Nakano T,Kanamoto A,et al.A case of advanced colon cancer successfully treated with combination therapy of cetuximab and oxaliplatin,leucovorin,and 5-fluorouracil[J].Gan To Kagaku Ryoho,2013,40(12):1962-1964.
  • 5Maughan TS,Adams RA,Smith CG,et al.Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer:results of the randomised phase 3 MRC COIN trial[J].Lancet,2011,377(9783):2103-2114.
  • 6Walker AS,Zwintscher NP,Johnson EK,et al.Future directions for monitoring treatment response in colorectal cancer[J].J Cancer,2014,5(1):44-57.
  • 7Power DG,Asmis TR,Tang LH,et al.High-grade neuroendocrine carcinoma of the colon,long-term survival in advanced disease[J].Med Oncol,2011,28(Suppl 1):169-174.
  • 8Siena S,Sartore-Bianchi A,Di Nicolantonio F,et al.Biomarkers predicting clinical outcome of epidermal growth factor receptor-targeted therapy in metastatic colorectal cancer[J].J Natl Cancer Inst,2009,101(19):1308-1324.
  • 9Dréanic J,Maillet M,Dhooge M,et al.Prognostic value of the Glasgow Prognostic Score in metastatic colorectal cancer in the era of anti-EGFR therapies[J].Med Oncol,2013,30(3):656.
  • 10Smith CG,Fisher D,Claes B,et al.Somatic profiling of the epidermal growth factor receptor pathway in tumors from patients with advanced colorectal cancer treated with chemotherapy±cetuximab[J].Clin Cancer Res,2013,19(15):4104-4113.

共引文献99

同被引文献32

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部